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Characterization of a lung 
epithelium specific E-cadherin 
knock-out model: Implications for 
obstructive lung pathology
S. Post1,2,4, I. H. Heijink1,2,3, L. Hesse1,2, H. K. Koo4, F. Shaheen4, M. Fouadi4, 
V. N. S. Kuchibhotla1,2, B. N. Lambrecht5,6,7, A. J. M. Van Oosterhout1,2, T. L. Hackett4 & 
M. C. Nawijn1,2
The airway epithelium regulates responses to aeroallergens, acting as a physical and immunological 
barrier. In asthma, epithelial barrier function and the expression of adherens junction protein 
E-cadherin is compromised, but it is unknown whether this is cause or consequence of the disease. 
We hypothesized that airway epithelial loss of E-cadherin is a critical step in the development of 
manifestations of asthma. We generated a transgenic mouse model with conditional loss of E-cadherin 
in lung epithelial cells at birth and onwards. We observed normal lung development at the time of birth 
in mice lacking E-cadherin in the lung epithelium. However, E-cadherin deficiency led to progressive 
epithelial damage in mice growing into adulthood, as evidenced by airway epithelial denudation, 
decreased zonula occludens (ZO)-1 expression, loss of ciliated cells, and enlarged alveolar spaces. In 
addition, spontaneous goblet cell metaplasia with mucus production was observed. These epithelial 
changes were accompanied by elevated levels of the epithelial-derived chemokine CCL17, infiltration of 
eosinophils and dendritic cells, and mucus production. In conclusion, loss of E-cadherin induces features 
in the lung reminiscent of those observed in asthma, indicating that the disruption of E-cadherin-
mediated cell-cell contacts may play a key role in the development of asthma manifestations.
The airway epithelium forms a structural and immunological barrier against environmental insults, such as 
inhaled allergens, viruses and particular matter. The pseudostratified airway epithelial layer that lines the con-
ducting airways is composed of basal/progenitor epithelial cells, columnar ciliated cells and mucus secreting cells, 
of which the latter two are responsible for mucociliary removal of inhaled environmental particulates. Epithelial 
barrier function is maintained by formation of tight and adherens junctions. Tight junctions are comprised of 
proteins such as occludin, zonula occludens (ZO)-1 and claudins, and maintain a size- and ion selective barrier, 
regulating the permeability of the epithelium1,2. Adherens junctions, which contain the transmembrane pro-
tein E-cadherin, are critical for maintaining apical-basolateral polarization and adhesion to neighboring cells3. 
E-cadherin-mediated contacts are thought to provide the architecture required to form the other junctional com-
plexes4. Additionally, E-cadherin has been shown to suppress intracellular signaling pathways, regulating epi-
thelial activation, proliferation and differentiation3. We have previously shown that siRNA down-regulation of 
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E-cadherin increases epidermal growth factor receptor (EGFR) activation, inducing expression of the pro-allergic 
C-C motif ligand 17 (CCL17) and thymic stromal lymphopoietin (TSLP) in human bronchial epithelial cells5.
In asthma, the airway epithelial barrier is often compromised, with epithelial denudation, goblet cell metapla-
sia, ciliary dysfunction and reduced expression of E-cadherin and ZO-11,6–10. This compromised airway epithelial 
barrier function has already been observed in children with asthma11. Asthma is a chronic inflammatory disease 
of the airways, characterized by eosinophilia, goblet cell metaplasia, airway hyperreactivity and airway remode-
ling including damage of the airway epithelium. Asthma susceptibility has a genetic component, and the disease 
is triggered by a hypersensitivity reaction following the interaction of genetic and specific environmental factors, 
such as aeroallergens, leading to a type-2 immune response.
Aeroallergens are known to directly and indirectly cause disruption of E-cadherin-mediated epithelial junc-
tions3. We previously reported that asthma-derived as well as transforming growth factor-beta (TGF)-β-treated 
airway epithelial cells12,13 are more prone to house dust mite (HDM)-induced barrier dysfunction. We further 
observed that the ability of HDM to induce barrier dysfunction is associated with its ability to induce aller-
gic sensitization and manifestations of asthma in vivo14. Intranasal HDM exposure has been reported to induce 
E-cadherin loss in vivo and lead to epithelial-to-mesenchymal transition (EMT), a process involved in tissue 
repair that has been implicated in airway remodeling in asthma15,16. It is currently unknown whether the loss of 
epithelial barrier function in asthma patients is a consequence or cause of the disease.
Since E-cadherin regulates airway epithelial structure, barrier function and innate immune responses3,5,12,15,16, 
we hypothesized that loss of airway epithelial loss of E-cadherin by itself is a critical step leading to the devel-
opment of asthma manifestations. To test our hypothesis, we generated lung epithelial specific, conditional 
E-cadherin deficient mice, as germ-line E-cadherin loss has previously been shown to be lethal17. We used 
sftpc-rtTA/(tetO)7-Cre mice, where pregnant dams were maintained on doxycycline to allow recombination of 
the conditional allele throughout the conducting airways and parenchyma, as all epithelial cells express surfactant 
protein C (SFTPC) during early development. Within the airways, SFTPC positive non-ciliated secretory cells 
called Club cells act as progenitor cells for the goblet and ciliated cells that are responsible for mucociliary clear-
ance18–20. Within the alveolar structures, SFTPC positive alveolar type II (ATII) cells serve as progenitors for the 
alveolar type I (ATI) cells that are responsible for gas exchange21. We investigated whether loss of E-cadherin in 
SFTPC expressing cells during early stages of life is accompanied by an altered airway epithelial phenotype and 
increased airway inflammation and remodeling later on in life.
Methods
Generation of E-cadherin knockout (Cdh1−/−) mice. Conditional E-cadherin knock-out mice 
(Cdh1fl/fl, B6.129-Cdh1tm2Kem/J), backcrossed onto the C57Bl/6 J background were purchased from Jackson 
Laboratory (Bar Harbor, ME). The compound transgenic sftpc-rtTA/(tetO)7-Cre mice that express the reverse tet-
racycline trans-activator (rtTA) under control of the rat SFTPC promoter were kindly provided by Prof. Geoffrey 
Whittset. The SFTPC promoter is expressed as early as day 10 of gestation in epithelial cells of the primordial lung 
buds22,23, causing all lung epithelial cells to express Cre recombinase under control of the tet operator (tetO)23. 
Cdh1fl/fl were crossed for two generations with sftpc-rtTA/(tetO)7-Cre mice to obtain both homozygous Cdh1fl/fl 
Cre+ mice (sftpc-rtTA/(tetO-)7Cre+/Cdh1fl/fl) and Cdh1fl/fl Cre− (sftpc-rtTA/(tetO)7-Cre−/Cdh1fl/fl) mice as litter-
mate controls. Pregnant dams were maintained on doxycycline24, to allow recombination of the conditional allele 
in all lung epithelial cells from the earliest developmental stages onward in Cre+ progeny. Genotyping was per-
formed as described in the online supplementary information.
Mice were kept under specific pathogen-free conditions and maintained on a 12-hour light-dark cycle, with 
food and water ad libitum. Cdh1fl/fl Cre+ and Cdh1fl/fl Cre− animals were mated and pregnant dams were fed 
doxycycline-containing chow (200 mg/kg; Bio-Serv, Frenchtown, NJ) until the end of the experiment. Mice were 
killed by anesthetizing the animals with isoflurane/oxygen (Nicholas Piramal India Ltd., London, UK) at the 
indicated time points (n = 5–7 mice per group), and bleeding them before removing the lungs. All animal exper-
iments were reviewed and approved by The Institutional Animal Care and Use Committee of the University of 
Groningen (The Netherlands) and Ghent (Belgium). All experiments were performed in accordance with relevant 
guidelines and regulations.
Measurement of airspace enlargement. The mean linear intercept (Lm) was used as morphomet-
ric parameter for quantifying airspace size. Histological lung sections, stained with hematoxylin, were imaged 
using Aperio Scanscope XT and representative samples (three per histological section) were obtained using the 
non-biased, Systematic Uniform Random Sampling (SURS) method as further detailed in the online supplemen-
tary information.
Immunochemistry, scanning electron microscopy (SEM), flow cytometry and cytokine assays 
in mouse lung tissue. Lungs were collected for morphometry analysis at day (D)0, week (W)2, W4 and 
W10 and processed for immunohistochemistry, flow cytometry (only for W2 and W4), see figure S1 in the online 
data supplement for the gating strategy), SEM, PCR or ELISA (only for W4) as described in the online supple-
mentary information. For the immunohistochemical analysis, staining and number of total airway epithelial cells 
per length of basement membrane was quantified using Image-Pro Plus. Cells per 500 µm basement membrane 
(5–25 counts per lung fragment) were counted. Mucus production was assessed by alcian blue staining and goblet 
cells were stained by Periodic-acid Schiff (PAS).
Statistics. The non-parametric Mann Whitney U test was performed to assess for significant differences 
between the Cdh1fl/fl Cre+ and Cdh1fl/fl Cre− mice for all analyses. P < 0.05 was considered statistically significant.
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Results
E-cadherin loss in the airway epithelium causes reduced airway epithelial cell numbers and 
epithelial denudation. To assess how the loss of E-cadherin within the lung epithelium affects lung devel-
opment, mice were euthanized on the day of birth (Day (D)0) and at week 4 and 10 of age (W4;W10). At birth, 
histologically the Cdh1fl/fl Cre+ mice displayed normal lung development and the loss of E-cadherin expression 
in the airway epithelium had no major effect on the development of the bronchi and bronchioles of the lung at 
this point. Staining for E-cadherin showed presence of E-cadherin in the airway epithelium of Cdh1fl/fl Cre− con-
trol littermates at birth, while E-cadherin was significantly reduced and only present in a few scattered airway 
epithelial cells of the Cdh1fl/fl Cre+ mice (Fig. 1A,B). At 4 W, airway epithelial E-cadherin expression remained 
significantly reduced (Fig. 1A,C), while E-cadherin expression was restored at W10 in the few remaining cells 
lining the airways (Fig. 1A,D). Accordingly, we observed that E-cadherin mRNA expression was reduced in lung 
homogenates of Cdh1fl/fl Cre+ mice at W4 (Fig. 1E), but not at W10 (Fig. 1F), while we were unable to collect lung 
tissue for RNA isolation at D0 because of the small size of the lungs.
Interestingly, from the age of W4 onward we observed a damaged airway epithelial layer throughout the lung 
of the Cdh1fl/fl Cre+ mice, with areas showing complete epithelial denudation (Fig. 1A).
We also assessed the effect of E-cadherin loss on tight junction formation by the expression of ZO-1 within 
the airway epithelium. While there was widespread expression of ZO-1 at D0, by W4 the percentage of positive 
staining for ZO-1 in Cdh1fl/fl Cre+ mice was significantly lower compared to control littermates. At W10, ZO-1 
expression was no longer significantly decreased in Cdh1fl/fl Cre+ mice (Fig S1 in the online data supplement).
Quantification of the number of total airway epithelial cells per length of basement membrane revealed that 
Cdh1fl/fl Cre+ mice were in fact born (D0) with significantly reduced airway epithelial cell numbers compared 
to their control littermates (Fig. 2A), and that the airways of these mice became more denuded at W4 and W10 
(Fig. 2B-C). The severity of the epithelial denudation was illustrated by SEM analysis, which revealed almost 
complete loss of epithelial lining in large regions of the airway lumen in the Cdh1fl/fl Cre+ mice compared to their 
control littermates already at the age of W4 (Fig. 2D).
Furthermore, when investigating lung morphology by hematoxylin staining, we observed striking infiltration 
of inflammatory cells (Fig. 2E).
E-cadherin deficiency in alveolar type II epithelium leads to increased mean airspace size. In 
addition to the loss of E-cadherin in airway epithelium, we observed E-cadherin loss in ATII cells, which nor-
mally express E-cadherin at each time point25. This demonstrates that loss of E-cadherin was induced throughout 
the lung epithelium. Microscopic evaluation of the lung parenchyma revealed that Cdh1fl/fl Cre+ mice displayed 
increased mean airspace size (Lm) at W4 and W10 compared to their control littermates (Fig. 3A). Cdh1fl/fl 
Cre+ mice demonstrated loss of E-cadherin in all intrapulmonary epithelial cells, including ATII cells (Fig. 3A). 
Histology analysis and measurement of mean airspace size (Lm) showed that, although Cdh1fl/fl Cre+ mice had 
a similar Lm to control Cdh1fl/fl Cre− littermates at the time of birth (Fig. 3B), Lm significantly increased in the 
Cdh1fl/fl Cre+ mice at W4 and W10 compared to control Cdh1fl/fl Cre− littermates (Fig. 3C-D) as further illustrated 
by HE staining (Fig. 3E). These results indicate that the loss of E-cadherin in ATII cells, the only alveolar cell type 
to express E-cadherin25, affects the overall lung structure inducing emphysematous lesions.
E-cadherin loss leads to spontaneous loss of ciliated cells and mucus hypersecretion indicating 
development of goblet cell metaplasia. To assess the effect of E-cadherin loss on airway epithelial 
differentiation, we performed immunohistochemistry staining using the cilia marker acetylated α-tubulin. We 
observed that acetylated α-tubulin expression was significantly reduced upon E-cadherin loss of in the airways of 
Cdh1fl/fl Cre+ mice at W4 and W10 but not at D0, compared to their Cdh1fl/fl Cre− control littermates (Fig. 4A–C). 
This was supported by scanning EM microscopy, revealing that E-cadherin deficiency induced loss of ciliated 
cell organization within the airways, with remaining ciliated cells scattered in a disorganized fashion along the 
airways, contrasting the rows of ciliated cells placed at regular intervals along the wild-type control airways 
(Fig. 4D). In contrast to the observed depletion of ciliated airway epithelial cells, we observed an increase in 
mucus production, as measured by increased alcian blue staining in Cdh1fl/fl Cre+ mice at W8 (Fig. 4F–H).
In addition, we assessed the expression of alpha-smooth muscle actin (α-SMA) within the airway epithelium 
to study if E-cadherin loss induced a more mesenchymal phenotype. We observed an increased expression of 
α-SMA in E-cadherin deficient airway epithelial cells at age W10, which was not present in the airways of Cre− 
control littermates (Figure 4JI).
Loss of E-cadherin results in a pro-inflammatory epithelial phenotype and innate immune activatio. 
As we hypothesized that loss of E-cadherin expression leads to increased production of pro-inflammatory 
cytokines and activation of an innate immune response, we next investigated the levels of epithelial derived 
chemokines and recruitment of inflammatory cells into the lung. We observed a significant increase in 
type-2 T cell attractant CCL17 in Cdh1fl/fl Cre+ mice compared to Cdh1fl/fl Cre− mice when mice reached the 
age of W4 (Fig. 5A), while levels of TSLP, C-C motif chemokine 11 (CCL11) and granulocyte-macrophage 
colony-stimulating factor (GM-CSF) were not different between the groups (Fig. 5B–D).
Next, we performed a detailed flow cytometric characterization of the infiltrated inflammatory cells observed 
by hematoxylin staining (Fig. 2E) in the lung tissue at W2 and W4 (Fig. 6A–H). We found that eosinophil num-
bers increase as early as at W2 in the lungs of Cdh1fl/fl Cre+ mice (Fig. 6A) compared to Cdh1fl/fl Cre− mice. This 
increase reached statistical significance at W4 (Fig. 6E). Additionally, we observed that the total dendritic cell 
(DC) population was significantly increased in the lungs of the Cdh1fl/fl Cre+ mice compared to their control 
littermates at W2 (Fig. 6B), but no longer at W4 (Fig. 6F). Interestingly, phenotyping the DC subpopulations at 
W2 showed that the CD103+ conventional (c)DC population was significantly elevated in Cdh1fl/fl Cre+ lungs 
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compared to Cdh1fl/fl Cre− lungs (Fig. 6C), while the inflammatory monocyte-derived DCs (moDCs) were signif-
icantly elevated in the Cdh1fl/fl Cre+ lungs at W4 (Fig. 6G). On the other hand, no effect was observed for CD11b+ 
cDCs at either 2 W or 4 W (Fig. 6C,G). Furthermore, total lymphocyte, neutrophil and macrophage numbers in 
the lungs were not affected by E-cadherin deficiency at any age (Fig. 6A,D,E,H). Together, these data show that 
Figure 1. E-cadherin expression in the lungs of E-cadherin knockout (Cdh1fl/fl Cre+) and wild type (Cdh1fl/fl  
Cre−) mice (n = 5–7 per group). (A) E-cadherin staining of airway epithelium at day (D)0 (I,IV), week (W) 4 
(II,V) and W10 (III,VI) of Cdh1fl/fl Cre−(I-III)/Cre+ (IV-VI) mice. Red arrows indicate epithelial denudation 
areas. Scale bars: 10 μm. Percentage of E-cadherin positive cell numbers as analyzed by Image-Pro Plus at (B) 
D0, (C) W4 and (D) W10. mRNA expression of E-cadherin (cdh1) in lung homogenates at (E) W4 and (F) 
W10. E-cadherin levels were related to the housekeeping genes hprt1 and pgk1 and expressed as 2−ΔCt. Medians 
are indicated. *p < 0.05, **p < 0.01 and ***p < 0.001 as assessed by the Mann Whitney U test.
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Figure 2. Characterization of airway epithelium in E-cadherin knockout (Cdh1fl/fl Cre+) and wild type 
(Cdh1fl/fl Cre−) mice. Analysis of percent total cells in the epithelium of Cdh1fl/fl Cre−/Cre+ mice at (A) day 
(D)0, (B) W4 and (C) W10, where the total cell count per 500 µm basement membrane (5–25 counts per lung 
fragment) per mouse is presented as percentage of the group average. Medians are indicated. (D) Electron 
microscopy images at W4, magnifications are as indicated. White arrows indicate epithelial denudation areas. 
(E) Hematoxylin staining in lung tissue of Cdh1fl/fl Cre−/Cre+ mice at W8, magnifications are as indicated. 
*p < 0.05, **p < 0.01 and ***p < 0.001 between the Cdh1fl/fl Cre+ and Cdh1fl/fl Cre− mice (n = 5–7 per group) 
as assessed by the Mann Whitney U test.
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Figure 3. Characterization of alveoli in E-cadherin knockout (Cdh1fl/fl Cre+) and wild type (Cdh1fl/fl Cre−) 
mice. (A) E-cadherin staining of alveoli at day (D)0 (I,IV), week (W)4 (II,V) and W10 (III,VI) of Cdh1fl/fl Cre− 
(I-III)/Cre+ (IV-VI) mice. Scale bars: 10 μm. Measurement of mean linear intercept (Lm) in the lung tissue at 
(B) D0, (C) W4 and (D) W10. (E) Hematoxylin staining in lung tissue of Cdh1fl/fl Cre−/Cre+ mice at D0, W4 
and W10. Scale bars, 100 μm. An average Lm was calculated from 3 randomly selected regions within each lung. 
Lm = Number of lines × Length of test line/Number of intersections. A greater Lm value therefore indicates 
increased air-space size.Medians are indicated. *p < 0.05, **p < 0.001 and ***p < 0.0001 between the Cdh1fl/fl 
Cre+ and Cdh1fl/fl Cre− mice (n = 5–7 per group) as assessed by the Mann Whitney U test.
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Figure 4. Loss of ciliated cells and increased mucus production in E-cadherin knockout (Cdh1fl/fl Cre+) and 
wild type (Cdh1fl/fl Cre−) mice. Analysis of percent ciliated cells at (A) day (D)0, (B) week (W)4 and (C) W10, 
where the ciliated cell count per mouse was calculated per 500 µm basement membrane (5–25 counts per 
lung fragment) as percentage of the group average. (D) Electron microscopy images at Week W6. Red arrow 
indicates loss of ciliated cells. Measurement of percentage alcian blue staining in the airways of Cdh1fl/fl  
Cre−/Cre+ mice at E) W4, (F) W8 and (G) W10, (H) Representative image of alcian blue staining of Cdh1fl/fl  
Cre−/Cre+ mice at W8. Scale bars, 10 μm. (I) Percentage of alpha-smooth muscle actin (α-SMA) positive 
cell numbers as analyzed by Image-Pro Plus in the airways of Cdh1fl/fl Cre−/Cre+ mice at W10. Medians are 
indicated. *p < 0.05 and **p < p0.01 between the Cdh1fl/fl Cre+ and Cdh1fl/fl Cre− mice (n = 5–7 per group) as 
assessed by the Mann Whitney U test.
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E-cadherin deficiency leads to pro-inflammatory activation of the lung epithelium that specifically attracts eosin-
ophilic granulocytes and inflammatory DCs into the airways.
Discussion
We show for the first time that conditional loss of E-cadherin results in airway epithelial denudation, loss of 
ciliated cells, spontaneous induction of mucus hypersecretion indicating goblet cell metaplasia and eosinophilic 
inflammation, all characteristics of asthma. Conditional loss of E-cadherin in the lung epithelium did not affect 
lung development up to birth. However, as the Cre+ mice aged, they developed airspace enlargement characteris-
tic of emphysematous lesions associated with loss of E-cadherin in ATII cells.
Our current study supports the hypothesis that loss of epithelial E-cadherin as observed in asthma has impor-
tant consequences, contributing to the pathogenesis of asthma, integrating structural and immunological regu-
latory functions within the airway epithelium3. Although E-cadherin is known to be critical for organogenesis 
of several epithelial tissues17,26, we observed a roughly normal lung anatomy at the time of birth in the Cdh1fl/fl 
Cre+ mice, with only very few epithelial cells expressing E-cadherin. This might be explained by the timing of 
E-cadherin loss in our model. A previous study showed that SFTPC-CAT expression at high levels was first 
detected as early as day 10 of gestation (E10) in epithelial cells (both airway epithelial cells and ATII cells) of the 
primordial lung buds23. Therefore, we anticipate that E-cadherin deficiency would not be introduced until the 
second week of gestation (~E10), when the primary lung epithelium has already formed, allowing normal devel-
opment of the lung. Nonetheless, SFTPC-driven Cre expression during embryonic development has previously 
been shown to induce recombination in all epithelial cells contributing to lung development, and was passed on 
to all lung epithelial cell into adulthood23. These data may explain our observation of normal lung development at 
birth, even with almost complete E-cadherin loss in the lung epithelium.
The lung morphology markedly changed when Cdh1fl/fl Cre+ mice reached an adult age, confirming that 
E-cadherin is a central regulator of lung structure and inflammation. Its loss resulted in epithelial denudation, 
Figure 5. Cytokine responses in E-cadherin knockout (Cdh1fl/fl /Cre+) and wild type (Cdh1fl/fl Cre−) mice.
Enzyme-linked immunosorbent assay (ELISA) analysis for (A) Chemokine (C-C motif) ligand 17 (CCL17), 
(B) Thymic stromal lymphopoietin (TSLP), (C) C-C motif chemokine 11 (CCL11) and (D) Granulocyte-
macrophage colony-stimulating factor (GM-CSF) levels in whole lung homogenates at week (W)4. Medians are 
indicated. **p < 0.01 between the Cdh1fl/fl Cre+ and Cdh1fl/fl Cre− mice (n = 5–7 per group) as assessed by the 
Mann Whitney U test.
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decreased ZO-1 expression, loss of ciliated cell numbers and organization, goblet cell metaplasia, and inflamma-
tory cell infiltration in the conducting airways as well as enlarged airspace size. These data are in line with a recent 
study demonstrating that E-cadherin is necessary for the differentiation of Club cells27, acting as progenitor cells 
Figure 6. Inflammatory responses in E-cadherin knockout (Cdh1fl/fl Cre+) mice) and wild type (Cdh1fl/fl Cre−) 
mice. Flow cytometry analysis for inflammatory cells in whole lungs of Cdh1fl/fl Cre−/Cre+ mice at (A) week 
(W)2 and (E) W4. Dendritic cell (DC) populations at (B) W2 and F) W4 and DC sub-populations (CD103+ 
conventional (c)DCs, CD11b + DCs and monocyte-derived (mo)DCs) at (C) W2 and (G) W4. Alveolar 
macrophages at (D) 2 W and (H) 4 W. Medians are indicated. *p < 0.05, **p < 0.01 or p value is as indicated 
between the Cdh1fl/fl Cre+ and Cdh1fl/fl Cre− mice (n = 5–7 per group) as assessed by the Mann Whitney U test.
www.nature.com/scientificreports/
1 0SCIENTIfIC RePORtS |  (2018) 8:13275  | DOI:10.1038/s41598-018-31500-8
for ciliated cells28. Postnatal inactivation of E-cadherin in mice impaired the repair of the conducting airway 
epithelium after site-specific Club cell injury27. We anticipate that a repair response is provoked in Cre+ mice 
upon the loss of E-cadherin, requiring proliferation and re-differentiation of Club cells progenitors to reconstruct 
a polarized, functionally intact ciliated epithelial layer. Lack of this process in Cdh1fl/fl Cre+ mice could be a con-
sequence of E-cadherin down-regulation in Club cells. Of note, basal side population cells that express breast 
cancer resistance protein (BCRP1), cytokeratin (CK)5 and p63 have been proposed as a major airway epithelial 
stem cell involved in repair of the conducting airways8. These BCRP1+CK5+p63+ cells are also capable of gen-
erating Club cell progenitors, but do not express transcription factors such as SFPTC, which are turned on later 
during development or regeneration. Therefore, these side population cells may be responsible for the recurrence 
of E-cadherin expressing cells in the bronchial epithelial lining of Cdh1fl/fl Cre+ mice at adult age, since these and 
their daughter cells are not affected by doxycycline-induced E-cadherin deficiency. Additionally, epithelial injury 
has been shown to induce Club cell metaplasia into mucus-producing cells in order to restore the damage20. Our 
data suggest that E-cadherin deficiency results in spontaneous goblet cell metaplasia, indicative of mucus hyper-
secretion by Club cells. In addition, we observed α-SMA expression in the epithelial layer, which could reflect 
a repair mechanism involving the transition to a more mesenchymal phenotype (e.g. EMT). In line, postnatal 
inactivation of E-cadherin was previously shown to induce WNT/β-catenin signaling, an important component 
of EMT, and bronchiolar metaplasia27. Expression of activated β-catenin in airway epithelium may not only result 
in EMT-like features, but has also been shown to result in goblet cell metaplasia through a mechanism involv-
ing down-regulation of mucus repressor Foxa229. Thus, the spontaneous goblet cell metaplasia in the Cdh1fl/fl  
Cre+ mice could be explained by dysregulated β-catenin signalling and abnormal repair responses. Another 
mechanism that could be involved in the observed mucus hypersecretion upon E-cadherin deficiency may be an 
increase in EGFR signalling, as we previously observed that loss of E-cadherin expression by airway epithelium 
in vitro leads to increased EGFR signalling30, which has been implicated in mucus production31. E-cadherin defi-
ciency also resulted in decreased tight junctional protein ZO-1, which is in line with previous studies that have 
shown that loss of E-cadherin impairs formation of tight junctions, leading to barrier dysfunction and reduced 
expression of ZO-13. These data along with studies in asthmatic airway epithelial biopsies that have previously 
shown decreased E-cadherin and ZO-1 expression6 further support the role of E-cadherin loss in compromised 
airway epithelial barrier function in asthma.
Alongside the airway epithelial changes, lungs of Cdh1fl/fl Cre+ mice showed enlarged airspaces with thinned 
and damaged septa, which became more pronounced with age. While asthma is considered mainly as an air-
way obstructive lung disease, a limited number of studies demonstrated parenchymal abnormalities in asthma 
patients, including centrilobular micronodules, mosaic perfusion and increased percent lower attenuation areas 
related to emphysematous changes32,33. In the parenchyma, specifically ATII cells express SFTPC, thus the SFTPC 
promotor ensured E-cadherin deficiency in ATII cells in our model. ATII cells function as a progenitor for alveo-
lar type I epithelium in rodents and humans34,35. In addition, ATII cells are responsible for the production of pul-
monary surfactant, which is required for epithelial integrity, adapting to breathing after birth by reducing surface 
tension in the alveolus36. Disruption of E-cadherin in mature ATII cells was previously shown to lead to diffuse 
hyperplasia and airspace enlargement37. Similarly, expression of activated β-catenin and of Foxa2 expression in 
mouse lungs resulted in aberrant ATII differentiation and airspace enlargement29,38. No formal study has investi-
gated whether the mechanism underlying the emphysematous changes in E-cadherin deficient mice involves loss 
of SFTPC+ATII cells or deregulated β-catenin signaling, needing further investigation.
In addition to direct effects on airway epithelium, we observed a striking pro-inflammatory response of the 
airway epithelium, as evidenced by the production of CCL17, finally resulting in airway inflammation char-
acterized by eosinophils and inflammatory dendritic cells. We have previously shown that down-regulation of 
E-cadherin expression in bronchial epithelial cells results in increased EGFR-induced expression of CCL17 and 
TSLP39. Additionally, E-cadherin loss may lead to activation of the nuclear factor-kappa B (NF-κB) and MAPK 
signaling pathways40. Both EGFR and NF-κB-mediated signaling can induce secretion of pro-inflammatory 
cytokines and chemokines, including CCL17, suggesting that the induction of E-cadherin loss by itself is suffi-
cient to induce pro-inflammatory activity of the airway epithelium12. In this way, loss of E-cadherin could lead 
to type-2 T cell-mediated eosinophilia. Alternatively, type-2 innate lymphocyte cells could be responsible for the 
observed eosinophils41, but this requires further investigation and will be subject of future studies. Of interest, 
loss of Foxa2 expression in lung epithelium in a mouse model not only induced goblet cell metaplasia, but also 
spontaneous pulmonary eosinophilic inflammation, recruitment of mDCs and type-2 T cells and increased levels 
of various chemokines, including CCL1742. As Foxa2 is known to activate the E-cadherin promoter43, loss of 
E-cadherin might play a central role in this phenotype given the striking similarities with our model. In addition, 
to the lung epithelium, CCL17 can be produced by CD103+ cDC and moDCs populations, which play a predom-
inant pro-inflammatory role in the development of asthma44. We observed significantly elevated levels of both 
CD103 (αEß7 integrin)+ cDC and moDCs in the lungs of the young adult Cdh1fl/fl Cre+ mice compared to their 
littermate controls. This may contribute to innate immune activation in the E-cadherin-deficient mice.
Our results in this novel mouse model of engineered loss of epithelial integrity strongly suggest that 
E-cadherin delocalization by itself may be sufficient for the development of airway inflammation. In line, struc-
tural changes in the airway epithelium as well as airway eosinophilic inflammation have been observed in the 
lungs of children before allergic asthma was even diagnosed45. In addition, a study of Ierodiakonou et al. showed 
that CDH1 gene polymorphisms are associated with airway remodeling and inflammation as well as lung func-
tions in asthmatic patients46, but only in patients using inhaled corticosteroids. Collectively, these studies and our 
data suggest that disruption of epithelial cell-cell contacts with junctional loss of E-cadherin are a crucial event 
in the development of asthma. In future studies, it will be of interest to assess whether the loss of E-cadherin also 
increases allergic sensitization.
www.nature.com/scientificreports/
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Taken together, our data show that loss of E-cadherin in lung epithelia induces spontaneous changes that have 
remarkable characteristics of an asthmatic phenotype, including progressive loss of airway epithelial cells, sponta-
neously mucus hypersecretion and eosinophilic airway inflammation. This indicates that loss of E-cadherin in the 
airway epithelium is not merely a consequence of disease, but actively contributes to the pathogenesis of asthma, 
identifying E-cadherin as a novel target for future therapeutic strategies.
Dataset Availability
The datasets generated during the current study are available from the corresponding author on reasonable re-
quest.
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